Skip to content
OpenCapital
Get started

Lantern Pharma LTRN Q1 2026 Annual earnings

Reported May 15, 2026 · After market close

EPS-$0.30Beat by $0.06
EPS estimate-$0.36

Next report

Aug 12, 2026 (In 2 weeks)
EPS estimate-$0.38

Versus estimates

Revenue

Q4 2024$100.7K

Diluted EPS

Q1 2026-$0.30Beat by $0.06
Q4 2025-$0.36Beat by $0.10Q3 2025-$0.39Beat by $0.07Q2 2025-$0.40Beat by $0.13Q1 2025-$0.42Beat by $0.07Q4 2024-$0.54Miss by $0.03

Ask the moment Lantern Pharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Lantern Pharma report Q1 2026 earnings?
Lantern Pharma (LTRN) reported Q1 2026 earnings on May 15, 2026 after market close.
What were Lantern Pharma's Q1 2026 revenue and EPS?
Lantern Pharma reported eps of $-0.30 for Q1 2026.
Did Lantern Pharma beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.36 by $0.06.
How did Lantern Pharma's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 28.6% from $-0.42.
Where can I find Lantern Pharma's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-023200) and the 10-K/A periodic report (0001493152-26-019713) directly on SEC EDGAR. The filing index links above go to sec.gov.